Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion type Assertion NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_head.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion wasGeneratedBy ECO_0000203 NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_provenance.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion wasDerivedFrom befree-2016 NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_provenance.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion SIO_000772 18381433 NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_provenance.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion evidence source_evidence_literature NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_provenance.
- NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_assertion description "[Moreover, overexpression of Mst1 sensitizes prostate cancer cells to cisplatin treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663350.RAgtlF3BYP52s_DYlOoKYsQtRMydNqkQk2ml74Ht3jzXY130_provenance.